Evidence shows that MC infiltration correlates with poor responses to anti-PD-1 therapy in several cancers [130,131,132] and that reducing or stabilizing MC numbers can improve responses to PD-1/PD-L1 inhibition [131,132,133]. The gene discussed is PDCD1; the disease is cancer.